MMJ Labs, LLC

Atlanta, GA · Digital health · Still private

FDA-qualified Clinical Outcome Assessment (COA) survey tool for measuring patient-reported opioid use and calculating morphine milligram equivalents (MME) in clinical trials

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · buzzy4shots.com

Sector: Digital health
Headquarters: Atlanta, GA
Total capital: $3.6M

Federal grants: $3.6M; 7 awards · 2019–2026; Sector median 0 awards
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 5; 5 pending · first 2016

Capital timeline

Latest events

May 2026Federal grantHealth and Human S · Phase II · Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)$347K
Jan 2025Federal grantHealth and Human S · Phase II · Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)$456K
Sep 2023Federal grantHealth and Human S · Phase I · Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) -a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)$159K
Feb 2023Federal grantHealth and Human S · Phase II · Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.$89K
Mar 2021Federal grantHealth and Human S · Phase II · Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.$689K
Apr 2020Federal grantHealth and Human S · Phase II · Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.$1.6M
Sep 2019Federal grantHealth and Human S · Phase II · Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.$222K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 5 granted of 10

Dec 5, 2023GrantedMechanical Oscillatory Stimulation Therapy DeviceUSPTOUS D1,006,997
Aug 25, 2022PendingSystem, Method And Apparatus For Pain Control And HealingUSPTOApplication 17742841
Jun 14, 2022GrantedSystem, Method And Apparatus For Pain Control And HealingUSPTOUS 11,357,698

Show all 10 patent records

Mechanical Oscillatory Stimulation Therapy DeviceDec 5, 2023 · US D1,006,997Granted
System, Method And Apparatus For Pain Control And HealingAug 25, 2022 · Application 17742841Pending
System, Method And Apparatus For Pain Control And HealingJun 14, 2022 · US 11,357,698Granted
Devices And Methods For Increased Blood Flow, Healing, And Pain ControlDec 27, 2018 · Application 16115484Pending
Device And Method For The Reduction Of Pain Associated With Needle SticksNov 6, 2018 · US 10,118,003Granted
Devices And Methods For Increased Blood Flow And Pain ControlAug 28, 2018 · US 10,058,476Granted
Device And Method For The Reduction Of Pain Associated With Needle SticksJun 7, 2016 · US 9,358,152Granted
Devices and Methods for Treatment and Promotion of Healing of Injured SitesApr 7, 2016 · Application 14874909Pending
Devices And Methods For Pain ControlApplication PCTUS2019048676Pending
Apparatus And Method For The Reduction Of Pain Using Vibration, Cold And Distractiv ElementsApplication PCTUS2007080497Pending

Regulatory activity · Digital health

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.